Vaxart Inc
VXRT0.320USD
-0.107-25.06%
取引時間 （ET）15分遅れの株価
73.03M時価総額
損失額直近12ヶ月PER
詳細情報 Vaxart Inc 企業名
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its development programs include pill vaccines designed to protect against norovirus (cause for acute gastroenteritis), coronavirus, including SARS-CoV-2 (COVID-19)), and influenza. In addition, it has generated preclinical data for its therapeutic vaccine candidate targeting cervical cancer and dysplasia caused by human papillomavirus. The Company's platform technology employs a vector-based approach and consists of various components, such as a vector (adenovirus type 5 (Ad5); an antigen (Ad5 DNA); an adjuvant (Toll-like receptor 3 (TLR3)), and its proprietary enteric-coated tablet.
企業情報
企業コードVXRT
会社名Vaxart Inc
上場日Mar 17, 1980
最高経営責任者「CEO」Mr. Steven (Steve) Lo
従業員数105
証券種類Ordinary Share
決算期末Mar 17
本社所在地170 Harbor Way, Suite 300
都市SOUTH SAN FRANCISCO
証券取引所US 'Other OTC' and Grey Market
国United States of America
郵便番号94080
電話番号16505503500
ウェブサイトhttps://vaxart.com/
企業コードVXRT
上場日Mar 17, 1980
最高経営責任者「CEO」Mr. Steven (Steve) Lo
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Edward B. Berg
Mr. Edward B. Berg
Senior Vice President, General Counsel
Senior Vice President, General Counsel
435.74K
+1053.17%
Mr. Jeroen Grasman
Mr. Jeroen Grasman
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
350.00K
--
Dr. Elaine J. Heron, Ph.D.
Dr. Elaine J. Heron, Ph.D.
Independent Director
Independent Director
51.65K
+44.88%
Mr. Steven (Steve) Lo
Mr. Steven (Steve) Lo
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.14K
-97.54%
Dr. Sean N. Tucker, Ph.D.
Dr. Sean N. Tucker, Ph.D.
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Mr. W. Mark Watson
Mr. W. Mark Watson
Independent Director
Independent Director
--
--
Dr. James F. Cummings, M.D.
Dr. James F. Cummings, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Matt Stein
Matt Stein
IR Contact Officer
IR Contact Officer
--
--
Mr. Kevin P. Finney
Mr. Kevin P. Finney
Independent Director
Independent Director
--
--
Ms. Laurie Hastings
Ms. Laurie Hastings
Senior Vice President of Human Resources
Senior Vice President of Human Resources
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Edward B. Berg
Mr. Edward B. Berg
Senior Vice President, General Counsel
Senior Vice President, General Counsel
435.74K
+1053.17%
Mr. Jeroen Grasman
Mr. Jeroen Grasman
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
350.00K
--
Dr. Elaine J. Heron, Ph.D.
Dr. Elaine J. Heron, Ph.D.
Independent Director
Independent Director
51.65K
+44.88%
Mr. Steven (Steve) Lo
Mr. Steven (Steve) Lo
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.14K
-97.54%
Dr. Sean N. Tucker, Ph.D.
Dr. Sean N. Tucker, Ph.D.
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Mr. W. Mark Watson
Mr. W. Mark Watson
Independent Director
Independent Director
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Fri, May 23
更新時刻: Fri, May 23
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
4.54%
Sio Capital Management, LLC
2.45%
Geode Capital Management, L.L.C.
1.17%
BlackRock Institutional Trust Company, N.A.
0.78%
Millennium Management LLC
0.42%
Other
90.64%
株主統計
株主統計
比率
The Vanguard Group, Inc.
4.54%
Sio Capital Management, LLC
2.45%
Geode Capital Management, L.L.C.
1.17%
BlackRock Institutional Trust Company, N.A.
0.78%
Millennium Management LLC
0.42%
Other
90.64%
種類
株主統計
比率
Investment Advisor
6.33%
Hedge Fund
3.23%
Investment Advisor/Hedge Fund
2.18%
Individual Investor
1.35%
Research Firm
0.26%
Pension Fund
0.05%
Bank and Trust
0.02%
Family Office
0.01%
Other
86.57%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
223
30.63M
13.42%
-33.98M
2025Q1
260
32.73M
14.34%
-33.64M
2024Q4
273
38.15M
16.82%
-29.38M
2024Q3
304
39.77M
17.54%
-31.47M
2024Q2
307
43.16M
19.03%
-9.14M
2024Q1
311
42.29M
24.34%
-1.37M
2023Q4
307
17.70M
11.60%
-12.17M
2023Q3
319
19.94M
13.09%
-20.38M
2023Q2
329
30.49M
20.10%
-12.31M
2023Q1
343
36.99M
27.31%
-14.55M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
10.37M
4.54%
+291.51K
+2.89%
Mar 31, 2025
Sio Capital Management, LLC
5.58M
2.45%
-5.93M
-51.51%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.66M
1.17%
+58.98K
+2.27%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.78M
0.78%
-9.61K
-0.54%
Mar 31, 2025
Millennium Management LLC
955.87K
0.42%
-2.03M
-68.04%
Mar 31, 2025
Squarepoint Capital LLP
804.48K
0.35%
+287.68K
+55.67%
Mar 31, 2025
State Street Global Advisors (US)
790.25K
0.35%
+101.40K
+14.72%
Mar 31, 2025
Finney Michael J
702.84K
0.31%
+16.00K
+2.33%
Jun 13, 2025
SilverArc Capital Management, LLC
683.83K
0.3%
-393.96K
-36.55%
Mar 31, 2025
Lee (Phillip E.)
631.62K
0.28%
+397.95K
+170.31%
Mar 24, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
Invesco RAFI US 1500 Small-Mid ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
比率0%
Invesco NASDAQ Future Gen 200 ETF
比率0%
Fidelity Nasdaq Composite Index ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
